메뉴 건너뛰기




Volumn 205, Issue 4, 2016, Pages

Lessons from the bedside: ketoacidosis and SGLT2 inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN; SODIUM GLUCOSE COTRANSPORTER 2;

EID: 85016282930     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/MJA16.00435     Document Type: Letter
Times cited : (5)

References (3)
  • 1
    • 84937763347 scopus 로고    scopus 로고
    • Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
    • Bonner C, Kerr-Conte J, Gmyr V, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 2015; 21: 512-517.
    • (2015) Nat Med , vol.21 , pp. 512-517
    • Bonner, C.1    Kerr-Conte, J.2    Gmyr, V.3
  • 2
    • 0018246065 scopus 로고
    • Hormonal regulation of ketone-body metabolism in man
    • Alberti KG, Johnston DG, Gill A, et al. Hormonal regulation of ketone-body metabolism in man. Biochem Soc Symp 1978; 43: 163-182.
    • (1978) Biochem Soc Symp , vol.43 , pp. 163-182
    • Alberti, K.G.1    Johnston, D.G.2    Gill, A.3
  • 3
    • 84959366596 scopus 로고    scopus 로고
    • Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: Possible mechanism and contributing factors
    • Ogawa W, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors. J Diabetes Investig 2016; 7: 135-138. n
    • (2016) J Diabetes Investig , vol.7 , pp. 135-138
    • Ogawa, W.1    Sakaguchi, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.